Published in Diabetologia on June 22, 2005
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab (2007) 8.91
Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol (2008) 5.37
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 3.51
Plasma 25-hydroxyvitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr (2008) 2.39
A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization. Global Health (2009) 2.12
Vitamin D and the immune system: new perspectives on an old theme. Endocrinol Metab Clin North Am (2010) 2.06
Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes. Diabetes Care (2011) 1.96
Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care (2013) 1.95
Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes (2007) 1.68
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res (2009) 1.67
Vitamin D deficiency and risk for cardiovascular disease. Am J Med Sci (2009) 1.62
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada (summary). CMAJ (2010) 1.59
Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep (2008) 1.54
Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ (2010) 1.45
Vitamin D and cognitive impairment in the elderly U.S. population. J Gerontol A Biol Sci Med Sci (2010) 1.41
25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int (2010) 1.34
No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes. Diabetes Care (2010) 1.26
Variation between countries in the frequency of diabetic ketoacidosis at first presentation of type 1 diabetes in children: a systematic review. Diabetologia (2012) 1.18
Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol Metab Clin North Am (2010) 1.18
Association of type 1 diabetes with month of birth among U.S. youth: The SEARCH for Diabetes in Youth Study. Diabetes Care (2009) 1.17
Vitamin D in HIV-Infected Patients. Curr HIV/AIDS Rep (2011) 1.11
Reduced serum vitamin D-binding protein levels are associated with type 1 diabetes. Diabetes (2011) 1.10
Vitamin D status among Adult Saudi Females visiting Primary Health Care Clinics. Int J Health Sci (Qassim) (2012) 1.09
Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) (2013) 1.07
Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC Public Health (2010) 1.07
Vitamin D and diabetes: let the sunshine in. Diabetes Educ (2008) 1.05
Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia (2012) 1.04
Vitamin D, cognitive dysfunction and dementia in older adults. CNS Drugs (2011) 1.03
No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial. Diabetes Care (2010) 1.03
A liquid chromatography/tandem mass spectrometry method for determination of 25-hydroxy vitamin D2 and 25-hydroxy vitamin D3 in dried blood spots: a potential adjunct to diabetes and cardiometabolic risk screening. J Diabetes Sci Technol (2009) 1.03
Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One (2013) 1.03
HbA(1c) levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weather conditions. Diabetologia (2010) 1.01
Glycemic changes after vitamin D supplementation in patients with type 1 diabetes mellitus and vitamin D deficiency. Ann Saudi Med (2010) 1.01
Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial. Daru (2012) 1.01
Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res Ther (2010) 0.99
1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol (2012) 0.97
Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines. PLoS One (2009) 0.96
Profiles of vitamin D insufficiency and deficiency in Japanese men and women: association with biological, environmental, and nutritional factors and coexisting disorders: the ROAD study. Osteoporos Int (2013) 0.96
Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol (2008) 0.94
Investigating the causal effect of vitamin D on serum adiponectin using a Mendelian randomization approach. Eur J Clin Nutr (2013) 0.93
To: Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48:1247-1257. Diabetologia (2005) 0.92
Vitamin D and pancreatic cancer. Ann Epidemiol (2008) 0.90
Race, vitamin D-binding protein gene polymorphisms, 25-hydroxyvitamin D, and incident diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr (2015) 0.90
Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: a cross-sectional epidemiological study. Cardiovasc Diabetol (2013) 0.88
No relationship between vitamin D status and insulin resistance in a group of high school students. J Clin Res Pediatr Endocrinol (2011) 0.86
Vitamin D receptor agonists target CXCL10: new therapeutic tools for resolution of inflammation. Mediators Inflamm (2013) 0.85
Clinical immunologic interventions for the treatment of type 1 diabetes. Cold Spring Harb Perspect Med (2012) 0.85
Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults. Eur J Nutr (2008) 0.85
Glycated haemoglobin is inversely related to serum vitamin D levels in type 2 diabetic patients. PLoS One (2013) 0.84
Association of serum 25-hydroxyvitamin D with insulin resistance and β-cell function in a healthy Chinese female population. Acta Pharmacol Sin (2013) 0.83
A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia (2014) 0.83
Seasonal variation of vitamin D and HbA(1c) levels in patients with type 1 diabetes mellitus in the Middle East. Int J Gen Med (2011) 0.83
Calcitriol plays a protective role in diabetic nephropathy through anti-inflammatory effects. Int J Clin Exp Med (2014) 0.82
Regulation of cathepsin G reduces the activation of proinsulin-reactive T cells from type 1 diabetes patients. PLoS One (2011) 0.81
Vitamins and type 2 diabetes mellitus. Endocr Metab Immune Disord Drug Targets (2015) 0.80
Type 2 diabetes, PUFAs, and vitamin D: their relation to inflammation. J Immunol Res (2014) 0.80
Assessment of 25(OH)D vitamin concentration in plasma of residents of Lodz with metabolic syndrome in pre- and postmenopausal period. Prz Menopauzalny (2014) 0.79
Vitamin D deficiency and altered bone mineral metabolism in HIV-infected individuals. Curr HIV/AIDS Rep (2014) 0.79
Levels of 25-hydroxyvitamin D in familial longevity: the Leiden Longevity Study. CMAJ (2012) 0.79
Vitamin D and Diabetic Complications: True or False Prophet? Diabetes Ther (2016) 0.78
Vitamin d and pancreatic cancer-an update. Cancers (Basel) (2011) 0.78
Vitamin D status predicts 30 day mortality in hospitalised cats. PLoS One (2015) 0.77
Impact of vitamin D deficiency on maternal and birth outcomes in the Saudi population: a cross-sectional study. BMC Pregnancy Childbirth (2016) 0.77
Vitamin D at the onset of type 1 diabetes in Italian children. Eur J Pediatr (2013) 0.77
The relationship between vitamin D status and HIV-related complications in HIV-infected children and young adults. Pediatr Infect Dis J (2013) 0.77
Enrichment of vitamin D response elements in RA-associated loci supports a role for vitamin D in the pathogenesis of RA. Genes Immun (2013) 0.77
Vitamin D status and associated factors in recent-onset type 1 diabetic children in Iran. J Diabetes Metab Disord (2012) 0.77
Potential causal associations between vitamin D and uric acid: Bidirectional mediation analysis. Sci Rep (2015) 0.76
Association of diabetes mellitus with a combination of vitamin d deficiency and arsenic exposure in the korean general population: analysis of 2008-2009 korean national health and nutrition examination survey data. Ann Occup Environ Med (2013) 0.76
The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Nutrients (2016) 0.76
1,25(OH)2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis). J Steroid Biochem Mol Biol (2016) 0.75
Relation of obesity with serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients. J Res Med Sci (2012) 0.75
Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord (2016) 0.75
Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. PLoS One (2013) 0.75
25-hydroxyvitamin D deficiency is associated with an increased risk of metabolic syndrome in patients with non-diabetic chronic kidney disease. Clin Nephrol (2012) 0.75
Alteration of vitamin D metabolic enzyme expression and calcium transporter abundance in kidney involved in type 1 diabetes-induced bone loss. Osteoporos Int (2010) 0.75
Pharmacogenetics of posttransplant diabetes mellitus. Pharmacogenomics J (2017) 0.75
Determinants of living situation in a population of community-dwelling and assisted living-dwelling elders. J Am Med Dir Assoc (2010) 0.75
The effects of vitamin d on insulin release from isolated islets of rats. Int J Endocrinol Metab (2015) 0.75
Anti-inflammatory effect of 1,25-dihydroxyvitamin D3 is associated with crosstalk between signal transducer and activator of transcription 5 and the vitamin D receptor in human monocytes. Exp Ther Med (2015) 0.75
Impact of Long-Term Poor and Good Glycemic Control on Metabolomics Alterations in Type 1 Diabetic People. J Clin Endocrinol Metab (2016) 0.75
Association of Serum 25-hydroxy-vitamin D Concentration and Arterial Stiffness among Korean Adults in Single Center. J Bone Metab (2017) 0.75
The Association between Vitamin D Deficiency and Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis of Observational Studies. Nutrients (2017) 0.75
Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis. Oncotarget (2017) 0.75
The Association of Serum 25-Hydroxyvitamin D Concentrations and Elevated Glycated Hemoglobin Values: A Longitudinal Study of Non-Diabetic Participants of a Preventive Health Program. Nutrients (2017) 0.75
Insufficient renal 1-alpha hydroxylase and bone homeostasis in aged rats with insulin resistance or type 2 diabetes mellitus. J Bone Miner Metab (2008) 0.75
ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy. KI Rep (2016) 0.75
Vitamin D status in tuberculosis patients with diabetes, prediabetes and normal blood glucose in China: a cross-sectional study. BMJ Open (2017) 0.75
Special considerations for vitamin D in the south Asian population in the UK. Ther Adv Musculoskelet Dis (2017) 0.75
Intensive insulin therapy in critically ill patients. N Engl J Med (2001) 40.00
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods (2001) 6.68
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. J Clin Invest (1981) 3.15
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax (2003) 2.68
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med (1990) 2.67
Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A (2001) 2.42
The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. J Biomol Tech (2003) 2.30
Thyroid function in patients with hyperemesis gravidarum. Am J Obstet Gynecol (1982) 1.87
Vitamin D-binding protein (Gc-globulin) binds actin. J Biol Chem (1980) 1.80
The measurement of the vitamin D-binding protein in human serum. J Clin Endocrinol Metab (1977) 1.73
Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia (1994) 1.68
Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology (1992) 1.62
Occult ectopic ACTH secretion due to recurrent lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide. Clin Endocrinol (Oxf) (1998) 1.43
IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice. Diabetologia (2003) 1.41
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. Gerontology (1996) 1.39
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab (1997) 1.38
Diabetic bone disease. Calcif Tissue Int (1991) 1.35
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus. Arteriosclerosis (1988) 1.30
1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes (1992) 1.30
Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab (1998) 1.30
Measurement of 25-hydroxyvitamin D3 in serum. Clin Chem (1976) 1.28
Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1 beta-exposed human and rat islet cells. Diabetologia (2001) 1.28
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. J Clin Endocrinol Metab (1999) 1.24
Intestinal calcium transporter genes are upregulated by estrogens and the reproductive cycle through vitamin D receptor-independent mechanisms. J Bone Miner Res (2003) 1.22
1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). Diabetes (2000) 1.20
Comparative study of the affinity of the serum vitamin D-binding protein. J Steroid Biochem (1980) 1.19
Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes (1990) 1.17
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. J Clin Invest (1997) 1.17
Coexistence of hypocalciuric hypercalcaemia and interstitial lung disease in a family: a cross-sectional study. Eur J Clin Invest (1985) 1.16
Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity. Q J Med (1985) 1.16
Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs. Curr Med Chem (2007) 1.15
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells. Mol Cell Endocrinol (1998) 1.15
In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J Bone Miner Res (2001) 1.14
Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women. Front Horm Res (1975) 1.13
C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol (1993) 1.13
The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem (1976) 1.13
Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. J Nucl Med (1997) 1.12
25-hydroxyvitamin D and its binding protein in maternal and cord serum. J Clin Endocrinol Metab (1977) 1.12
Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res (1999) 1.12
Etiology of hypercalcemia in a patient with Addison's disease. Calcif Tissue Int (1982) 1.12
Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol (2000) 1.10
Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab (1980) 1.10
Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. Endocrinology (1992) 1.10
The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. J Clin Endocrinol Metab (1975) 1.10
25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab (2014) 1.10
Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. Am J Clin Nutr (1994) 1.09
The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. J Endocrinol (1992) 1.08
Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency. J Bone Miner Res (2000) 1.07
Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb (1992) 1.06
Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. Endocrinology (1995) 1.06
Vitamin D: do we get enough? A discussion between vitamin D experts in order to make a step towards the harmonisation of dietary reference intakes for vitamin D across Europe. Osteoporos Int (2012) 1.05
Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol (1995) 1.05
Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J Neuroimmunol (1995) 1.03
Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet (2000) 1.03
A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem (1980) 1.02
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. Curr Med Res Opin (2008) 1.02
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃. Best Pract Res Clin Endocrinol Metab (2011) 1.02
Chromogranin A: its clinical value as marker of neuroendocrine tumours. Eur J Clin Invest (1998) 1.02
Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. J Invest Dermatol (1997) 1.01
p38 mitogen-activated protein kinase regulates a novel, caspase-independent pathway for the mitochondrial cytochrome c release in ultraviolet B radiation-induced apoptosis. J Biol Chem (2000) 1.01
Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J Clin Endocrinol Metab (1984) 1.00
The role of the plasminogen system in bone resorption in vitro. J Bone Miner Res (1999) 1.00
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. J Clin Endocrinol Metab (1997) 1.00
The isolation and characterization of the vitamin D-binding protein from rat serum. J Biol Chem (1978) 0.99
Space flight: a challenge for normal bone homeostasis. Crit Rev Eukaryot Gene Expr (2001) 0.99
Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology (1997) 0.98
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab (2001) 0.98
Pancreatic secretion in man with subclinical vitamin D deficiency. Diabetologia (1986) 0.98
Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. Endocrinology (1989) 0.98
Characteristics of the vitamin D binding protein in different species. Calcif Tissue Res (1976) 0.98
Gene expression related to the differentiation of osteoblastic cells is altered by microgravity. Bone (1998) 0.97
Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology (1998) 0.97
Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation. Oncogene (2011) 0.96
Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. Biochem Biophys Res Commun (2001) 0.96
Deletion of C/EBP homologous protein (Chop) in C57Bl/6 mice dissociates obesity from insulin resistance. Diabetologia (2012) 0.95
Vitamin D metabolism in breast-fed infants and their mothers. Pediatr Res (1989) 0.95
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. J Clin Endocrinol Metab (1998) 0.95
Increased bone formation in mice lacking plasminogen activators. J Bone Miner Res (2003) 0.95
Microgravity reduces the differentiation of human osteoblastic MG-63 cells. J Bone Miner Res (1997) 0.94
Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance. Scand J Clin Lab Invest Suppl (1997) 0.94
Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway. J Steroid Biochem Mol Biol (2006) 0.93
Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. Endocrinology (1984) 0.93
NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J Autoimmun (2004) 0.93
Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. Bone (2000) 0.93
Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone. J Bone Miner Res (2002) 0.92
Binding of 25-hydroxycholecalciferol in tissues. J Biol Chem (1977) 0.92
Diagnostic fine-needle aspiration cytology and immunocytochemistry analysis of a primary thyroid lymphoma presenting as an anatomic emergency. Thyroid (2002) 0.92
Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3. Clin Exp Immunol (1993) 0.92
25-hydroxy-vitamin-D in nephrotic syndrome. Lancet (1977) 0.92
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy. Oncogene (2008) 0.92
The heterogeneity of human Gc-globulin. J Biol Chem (1978) 0.92
Mineral and bone metabolism in thyroid disease: a review. Q J Med (1986) 0.92
Changes in biochemical markers of osteoblastic activity during the menstrual cycle. J Clin Endocrinol Metab (1990) 0.91
Effects of short-term insulin-like growth factor-I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man. J Intern Med (1997) 0.91